Download PDF
1 / Pages

Other users also viewed these articles

ß2-agonistas en asma: el extraño caso del Dr. Jekyll y Mr. Hyde Xavier Muñoz; Christian Romero-Mesones; María Jesús Cruz;
Arch Bronconeumol. 2020;56:204-5
Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction? Nan Zhao; Samy Suissa; Pierre Ernst;
Arch Bronconeumol. 2023;59:354-5
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes Helen K. Reddel; Leonard B. Bacharier; Eric D. Bateman; Christopher E. Brightling; Guy G. Brusselle; Roland Buhl; Alvaro A. Cruz; Liesbeth Duijts; Jeffrey M. Drazen; J. Mark FitzGerald; Louise J. Fleming; Hiromasa Inoue; Fanny W. Ko; Jerry A. Krishnan; Mark L. Levy; Jiangtao Lin; Kevin Mortimer; Paulo M. Pitrez; Aziz Sheikh; Arzu A. Yorgancioglu; Louis-Philippe Boulet;
Arch Bronconeumol. 2022;58:35-51